Biotech Market Intelligence & Analysis
In-depth articles on the biotech landscape — market analysis, sector reports, funding trends, and company spotlights.
Clinical Trial Success Rates by Phase: What the Data Shows
For biotech investors, the clinical trial pathway is the definitive arena where scientific promise is stress-tested against biological reality. The probability of a drug candidate advancing from first-in-human studies to regulatory approval is the single most critical metric for de-risking a pipelin
Biotech IPOs: Complete Guide to Going Public
For biotechnology companies, the decision to go public is rarely a simple matter of ambition. It is a critical, capital-intensive milestone on the path from scientific discovery to commercial therapy. The biotech model is fundamentally built on a cycle of high-risk, high-reward r
Gene Therapy Companies: A Complete Landscape Guide
The fundamental premise of gene therapy—to treat or cure disease by correcting, replacing, or modulating defective genes—has evolved from a scientific aspiration into a commercial and clinical reality. After decades of setbacks and incremental progress, the field has entered a ne